Formerly doing business as Respira Labs LLC, Samay LLC is building an AI-powered sensor platform designed to track, predict and prevent chronic lung disease. Developing what may be the first AI-enabled wearable device continuously monitoring lung function and to prevent COPD attacks, the firm's technology incorporates active acoustic sensors within a wearable device secured to the chest that can be used 24/7 - in real time, continuously tracing and able to identify abnormalities in lung function: effectively a monitoring service enabling health providers to act earlier and prevent complications. With no reliable and validated methods currently available to detect COPD exacerbations in time for early intervention and prevention. the firm's device effectively measures trapped air, an early marker of Chronic Obstructive Pulmonary Disease (COPD). By leveraging the power of non-invasive acoustic sensors, audio signal processing, machine learning and Acoustic Resonance Index Analysis (ARIA), Respira's device could fundamentally change COPD management: predicting and preventing attacks at patients home, significantly improving health outcomes and patient quality of life while dramatically lowering health care c
